WallStSmart
SKYE

Skye Bioscience, Inc. Common Stock

NASDAQ: SKYE · HEALTHCARE · BIOTECHNOLOGY

$0.88
-1.71% today

Updated 2026-04-30

Market cap
$22.94M
P/E ratio
P/S ratio
EPS (TTM)
$-1.30
Dividend yield
52W range
$1 – $6
Volume
0.6M

Skye Bioscience, Inc. Common Stock (SKYE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-39.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-26.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+20.8%
2025-12-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.37-20.2%$0.73$0.88+20.8%
2025-11-10$-0.32-39.1%$1.53$1.46-4.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.31$-0.37-20.2%
2025-09-30$-0.23$-0.32-39.1%
2025-06-30$-0.22$-0.44-100.0%
2025-03-31$-0.29$-0.28+3.4%
2024-12-31$-0.29$-0.29-2.2%
2024-09-30$-0.25$-0.10+60.0%
2024-06-30$-0.19$-0.20-5.3%
2024-03-31$-0.16$-0.18-12.5%
2023-12-31$-0.38$-0.63-65.8%$163389.00
2023-09-30$0.00$-3.17
2023-06-30$0.00$-0.00
2023-03-31$0.00$-0.01

Frequently asked questions

Has Skye Bioscience, Inc. Common Stock beaten earnings estimates?
Skye Bioscience, Inc. Common Stock has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -39.0% over the last 4 quarters.
How does SKYE stock react to earnings?
SKYE stock has moved an average of +8.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.